Herein, we have shown that MED can significantly inhibit the ox-LDL-induced expression of TNF-α, IL-6, and IL-1β both in RAW264.7 cells and in plaque lesion areas, which suggests that MED can suppress inflammatory responses in atherosclerosis. Here, IL6 is linked to atherosclerosis.